The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring
NCT ID: NCT03155854
Last Updated: 2025-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2016-09-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Subjects are being asked to take part in this research study because they have been diagnosed with trigger finger and pretendinous Dupuytren's cord and have decided to undergo surgery rather than try medical treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
NCT05440240
Splinting for Dupuytren's Contracture Release
NCT00575458
Post-contracture Release Radiation for Dupuytren's Disease
NCT04122313
Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease
NCT03000114
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
NCT00014742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pretendinous cord excision
Patients will undergo either a targeted palmar fasciectomy procedure in which the involved Dupuytren's fascia will be excised
Pretendinous cord excision
The cord/palmar fascia will be excised during surgery.
Division/manipulation of the cord
patients will undergo either a targeted palmar fasciectomy procedure in which the involved Dupuytren's fascia will be incised.
Division/manipulation of the cord
The pretendinous cord will be divided and incised during surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pretendinous cord excision
The cord/palmar fascia will be excised during surgery.
Division/manipulation of the cord
The pretendinous cord will be divided and incised during surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sanjeev (Sanj) Kakar, M.D., M.B.A.
Professor of Orthopedics,
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sanjeev Kakar, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-008280
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.